ABSI Logo

Absci Corporation (ABSI) 

NASDAQ
Market Cap
$343.42M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
142 of 960
Rank in Industry
99 of 550

Largest Insider Buys in Sector

ABSI Stock Price History Chart

ABSI Stock Performance

About Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Insider Activity of Absci Corporation

Over the last 12 months, insiders at Absci Corporation have bought $999,999 and sold $13.74M worth of Absci Corporation stock.

On average, over the past 5 years, insiders at Absci Corporation have bought $27.22M and sold $13.74M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Redmile Group, LLC (director) — $13M.

The last purchase of 222,222 shares for transaction amount of $999,999 was made by Redmile Group, LLC (director) on 2024‑03‑01.

List of Insider Buy and Sell Transactions, Absci Corporation

2024-06-13SaleCFO / CBO
19,859
0.0194%
$4.98$98,892-10.30%
2024-05-22Sale10 percent owner
3.1M
2.6164%
$4.40$13.64M-13.85%
2024-03-01Purchasedirector
222,222
0.1982%
$4.50$999,999-22.39%
2022-02-09PurchaseGeneral Counsel
4,250
0.0044%
$7.96$33,830-59.91%
2022-01-20PurchaseVP, CCPAO
2,000
0.0023%
$7.50$15,000-50.42%
2022-01-19PurchasePresident and Chief Executive
7,155
0.0081%
$6.92$49,513-47.79%
2021-07-26Purchasedirector
1.88M
1.7426%
$16.00$30M-63.43%
2021-07-26Purchasedirector
1.56M
1.4521%
$16.00$25M-63.43%
2021-07-26Purchasedirector
1.56M
1.4521%
$16.00$25M-63.43%
2021-07-26PurchasePresident and Chief Executive
600
0.0006%
$16.00$9,600-63.43%
2021-07-26Purchasedirector
15,000
0.0139%
$16.00$240,000-63.43%
2021-07-26PurchaseGeneral Counsel
10,000
0.0093%
$16.00$160,000-63.43%
2021-07-26Purchasedirector
9,000
0.0084%
$16.00$144,000-63.43%
2021-07-26PurchaseVP, CCPAO
1,000
0.0009%
$16.00$16,000-63.43%

Insider Historical Profitability

<0.0001%
Redmile Group, LLCdirector
8253316
7.1858%
$2.9920<0.0001%
Jonasson ZachariahCFO / CBO
384751
0.335%
$2.9911<0.0001%
Casdin Elidirector
6745333
5.8729%
$2.9910<0.0001%
Casdin Partners Master Fund, L.P.director
6745333
5.8729%
$2.9910<0.0001%
McClain SeanPresident and Chief Executive
6368955
5.5452%
$2.9920<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Fidelity Investments$84.12M13.114.81M+6.85%+$5.39M0.01
Redmile Group$46.88M7.38.25M+2.77%+$1.26M0.48
Alger$42.08M6.557.41MNew+$42.08M0.21
The Vanguard Group$19.57M3.053.45M+33.74%+$4.94M<0.0001
ARK Investment Management LLC$18.61M2.93.28MNew+$18.61M0.06
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.